Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting

Journal of Clinical Oncology

Volumn 7, Issue 8, 1989, Pages 1137-1141

  Grunberg, S M ^a   Stevenson, L L ^a   Russell, C A ^a   McDermed, J E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIEMETIC AGENT; CISPLATIN; ONDANSETRON; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; DRUG THERAPY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LACRIMATION; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RASH; SEDATION; SIDE EFFECT; VERTIGO; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

EID: 0024335838     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1989.7.8.1137     Document Type: Article

References (0)